Most Recent

image: Popular Tumor Cell Line Contaminated

Popular Tumor Cell Line Contaminated

By | August 31, 2016

A commercially available glioblastoma cell line appears to be from a different source than its stated origins.

0 Comments

image: One Receptor, Two Ligands, Different Responses

One Receptor, Two Ligands, Different Responses

By | August 31, 2016

Host and bacterial ligands that interact with the same cell-surface receptor induce different activities in human macrophages. 

0 Comments

image: One Antigen Receptor Induces Two T cell Types

One Antigen Receptor Induces Two T cell Types

By | August 26, 2016

Precursor T cells bearing the same antigen receptor adopt two different fates in mice.

1 Comment

image: Book Excerpt from <em>Seven Skeletons</em>

Book Excerpt from Seven Skeletons

By | August 1, 2016

In Chapter 1, “The Old Man of La Chapelle: The Patriarch of Paleo,” author Lydia Pyne explains the public's evolving conception of the first complete Neanderthal skeleton found and described by scientists.

1 Comment

By ditching traditional agar-based media, two biochemists captured iconic images of Myxococcus in 1982.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | August 1, 2016

Brexit's effect on science, melding disciplines, and more

0 Comments

image: Wanted: Transcriptional Regulators

Wanted: Transcriptional Regulators

By | August 1, 2016

Researchers have designed a screen to find unique molecules, called riboswitches, that determine whether transcription will proceed.

0 Comments

A 3-D carbon nanotube mesh enables rat spinal tissue sections to reconnect in culture.

2 Comments

Mismatched ancestral origins of mitochondrial and nuclear DNA boost mouse health.

1 Comment

image: Book Excerpt from <em>Blood Sugar</em>

Book Excerpt from Blood Sugar

By | July 1, 2016

Author Anthony Ryan Hatch relays his personal experience with metabolic syndrome.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech